N-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide

C168H336N24O14 — CID 159464538

IUPACN-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide
SMILESCCCCCCCCCC(=O)C(CCCN)NC(=O)CCCCCCC.CCCCCCCCCC(=O)C(CCCN=C(N)N)NC(=O)CCCCCCC.CCCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)CCC.CCCCCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)CCCCCCCCC.CCCCCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)CCCCCCCCCCC.CCCCCCCCCCCCC(=O)C(CCCN)NC(=O)CCCCCCC.CCCCCCCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)CCC
InChIInChI=1S/C29H58N4O2.C27H54N4O2.C25H50N2O2.2C23H46N4O2.C22H44N2O2.C19H38N4O2/c1-3-5-7-9-11-13-15-17-19-23-27(34)26(22-21-25-32-29(30)31)33-28(35)24-20-18-16-14-12-10-8-6-4-2;1-3-5-7-9-11-12-14-16-18-22-26(33)31-24(20-19-23-30-27(28)29)25(32)21-17-15-13-10-8-6-4-2;1-3-5-7-9-10-11-12-13-15-16-20-24(28)23(19-18-22-26)27-25(29)21-17-14-8-6-4-2;1-3-5-6-7-8-9-10-11-12-13-14-18-22(29)27-20(21(28)16-4-2)17-15-19-26-23(24)25;1-3-5-7-9-10-12-13-17-21(28)20(16-15-19-26-23(24)25)27-22(29)18-14-11-8-6-4-2;1-3-5-7-9-10-12-13-17-21(25)20(16-15-19-23)24-22(26)18-14-11-8-6-4-2;1-3-5-6-7-8-9-10-14-18(25)23-16(17(24)12-4-2)13-11-15-22-19(20)21/h26H,3-25H2,1-2H3,(H,33,35)(H4,30,31,32);24H,3-23H2,1-2H3,(H,31,33)(H4,28,29,30);23H,3-22,26H2,1-2H3,(H,27,29);2*20H,3-19H2,1-2H3,(H,27,29)(H4,24,25,26);20H,3-19,23H2,1-2H3,(H,24,26);16H,3-15H2,1-2H3,(H,23,25)(H4,20,21,22)
InChIKeyLUZXJUKTUKKPQQ-UHFFFAOYSA-N
MW2916.69 g/mol
LogP37.05
Rot. Bonds147

About N-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide

N-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide (PubChem CID 159464538) has the molecular formula C168H336N24O14 and a molecular weight of 2916.69 g/mol. Its IUPAC name is N-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide.

Molecular Properties

Compound NameN-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide
PubChem CID159464538
Molecular FormulaC168H336N24O14
Molecular Weight2916.69 g/mol
Exact Mass2914.63
IUPAC NameN-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide
SMILESCCCCCCCCCC(=O)C(CCCN)NC(=O)CCCCCCC.CCCCCCCCCC(=O)C(CCCN=C(N)N)NC(=O)CCCCCCC.CCCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)CCC.CCCCCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)CCCCCCCCC.CCCCCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)CCCCCCCCCCC.CCCCCCCCCCCCC(=O)C(CCCN)NC(=O)CCCCCCC.CCCCCCCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)CCC
InChIInChI=1S/C29H58N4O2.C27H54N4O2.C25H50N2O2.2C23H46N4O2.C22H44N2O2.C19H38N4O2/c1-3-5-7-9-11-13-15-17-19-23-27(34)26(22-21-25-32-29(30)31)33-28(35)24-20-18-16-14-12-10-8-6-4-2;1-3-5-7-9-11-12-14-16-18-22-26(33)31-24(20-19-23-30-27(28)29)25(32)21-17-15-13-10-8-6-4-2;1-3-5-7-9-10-11-12-13-15-16-20-24(28)23(19-18-22-26)27-25(29)21-17-14-8-6-4-2;1-3-5-6-7-8-9-10-11-12-13-14-18-22(29)27-20(21(28)16-4-2)17-15-19-26-23(24)25;1-3-5-7-9-10-12-13-17-21(28)20(16-15-19-26-23(24)25)27-22(29)18-14-11-8-6-4-2;1-3-5-7-9-10-12-13-17-21(25)20(16-15-19-23)24-22(26)18-14-11-8-6-4-2;1-3-5-6-7-8-9-10-14-18(25)23-16(17(24)12-4-2)13-11-15-22-19(20)21/h26H,3-25H2,1-2H3,(H,33,35)(H4,30,31,32);24H,3-23H2,1-2H3,(H,31,33)(H4,28,29,30);23H,3-22,26H2,1-2H3,(H,27,29);2*20H,3-19H2,1-2H3,(H,27,29)(H4,24,25,26);20H,3-19,23H2,1-2H3,(H,24,26);16H,3-15H2,1-2H3,(H,23,25)(H4,20,21,22)
InChIKeyLUZXJUKTUKKPQQ-UHFFFAOYSA-N
XLogP37.05
TPSA697.23 Ų
H-Bond Donors19
H-Bond Acceptors21
Rotatable Bonds147
Heavy Atoms206
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002916.69
LogP ≤ 537.05
H-Bond Donors ≤ 519
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze N-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide?
The IUPAC name of N-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide (CID 159464538) is N-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide.
What is the SMILES notation for N-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide?
The canonical SMILES for N-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide is CCCCCCCCCC(=O)C(CCCN)NC(=O)CCCCCCC.CCCCCCCCCC(=O)C(CCCN=C(N)N)NC(=O)CCCCCCC.CCCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)CCC.CCCCCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)CCCCCCCCC.CCCCCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)CCCCCCCCCCC.CCCCCCCCCCCCC(=O)C(CCCN)NC(=O)CCCCCCC.CCCCCCCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)CCC.
What is the InChIKey of N-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide?
The InChIKey is LUZXJUKTUKKPQQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H58N4O2.C27H54N4O2.C25H50N2O2.2C23H46N4O2.C22H44N2O2.C19H38N4O2/c1-3-5-7-9-11-13-15-17-19-23-27(34)26(22-21-25-32-29(30)31)33-28(35)24-20-18-16-14-12-10-8-6-4-2;1-3-5-7-9-11-12-14-16-18-22-26(33)31-24(20-19-23-30-27(28)29)25(32)21-17-15-13-10-8-6-4-2;1-3-5-7-9-10-11-12-13-15-16-20-24(28)23(19-18-22-26)27-25(29)21-17-14-8-6-4-2;1-3-5-6-7-8-9-10-11-12-13-14-18-22(29)27-20(21(28)16-4-2)17-15-19-26-23(24)25;1-3-5-7-9-10-12-13-17-21(28)20(16-15-19-26-23(24)25)27-22(29)18-14-11-8-6-4-2;1-3-5-7-9-10-12-13-17-21(25)20(16-15-19-23)24-22(26)18-14-11-8-6-4-2;1-3-5-6-7-8-9-10-14-18(25)23-16(17(24)12-4-2)13-11-15-22-19(20)21/h26H,3-25H2,1-2H3,(H,33,35)(H4,30,31,32);24H,3-23H2,1-2H3,(H,31,33)(H4,28,29,30);23H,3-22,26H2,1-2H3,(H,27,29);2*20H,3-19H2,1-2H3,(H,27,29)(H4,24,25,26);20H,3-19,23H2,1-2H3,(H,24,26);16H,3-15H2,1-2H3,(H,23,25)(H4,20,21,22).
What are the key properties of N-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide?
N-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide has a molecular weight of 2916.69 g/mol, XLogP of 37.05, 147 rotatable bonds, 19 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1-amino-5-oxoheptadecan-4-yl)octanamide;N-(1-amino-5-oxotetradecan-4-yl)octanamide;N-[1-(diaminomethylideneamino)-5-oxohexadecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]decanamide;N-[1-(diaminomethylideneamino)-5-oxooctan-4-yl]tetradecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]dodecanamide;N-[1-(diaminomethylideneamino)-5-oxotetradecan-4-yl]octanamide is sourced from PubChem (CID 159464538), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).